MilliporeSigma invests US$ 76 million to expand ADC manufacturing in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
The partnership emphasises the introduction of renewable, bio-based materials into existing plastic applications to help reduce fossil resource dependency
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
The Pediatric vaccine portfolio delivered double-digit growth and maintained its market leadership in the private market
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Silica is a proven and highly effective anti-caking agent that has been used for decades
Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
Subscribe To Our Newsletter & Stay Updated